Press Releases from BioMedReports (1 total)
CEO of emerging NanoAntibiotics says firm is poised for growth in biotech’s po …
Jonathan Adams is CEO of NanoAntibiotics, Inc. (OTCQB:NNAB [nanoantibiotics.com], which will soon change its name to BioVie. He has been working in pharma/biotech since graduating with his MBA from Dartmouth/Tuck in 1989, and earlier in his career assisted with the launch of Celebrex and many other drug therapies. A key member of his team is Cuong Do, who brings decades of industry experience, including as the former head of strategy…
